Yonghao Liang

Yonghao Liang

Auto-generated profile, based on publicly available information

Yonghao Liang

Department of Genetics, Washington University School of Medicine, St. Louis, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NSNakul M. Shah
Nakul M. Shah
HJH. Josh Jang
H. Josh Jang
YLYonghao Liang
Yonghao Liang
JMJu Heon Maeng
Ju Heon Maeng
STShin-Cheng Tzeng
Shin-Cheng Tzeng
TWTing Wang
Ting Wang

16 January 2024 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
YLYonghao Liang
Yonghao Liang
XQXuan Qu
Xuan Qu
NSNakul M. Shah
Nakul M. Shah
TWTing Wang
Ting Wang

2 September 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HJH. Josh Jang
H. Josh Jang
NSNakul M. Shah
Nakul M. Shah
JMJu Heon Maeng
Ju Heon Maeng
YLYonghao Liang
Yonghao Liang
NBNoah L. Basri
Noah L. Basri
TWTing Wang
Ting Wang

13 May 2025 in Genome Research
Verified
Journal Article
Open access
PDF file
XQXuan Qu
Xuan Qu
YLYonghao Liang
Yonghao Liang
CMColin McCornack
Colin McCornack
XXXiaoyun Xing
Xiaoyun Xing
HSHeather Schmidt
Heather Schmidt
TWTing Wang
Ting Wang
The relationship between TP53 and transposable elements (TEs) has been obscure. Given the important role of TEs in oncogenesis, a comprehensive profiling of TE expression dynamics under the regulation of TP53 provides valuable resources for more clarity in TP53's roles in cancer. In this study, we characterized the TE transcriptomic landscape using long-read RNA-seq and short-read RNA-seq in three cancer cell lines varying only inTP53genetic status. To identify transcripts that use TEs as potential promoters, we developed a computational pipeline, TEProf3, and identified in total 1942 transcripts with high confidence. Among these TE-derived transcripts, 239 are activated by TP53 and 221 are repressed by TP53. These TP53-responsive TE-derived transcripts are mainly driven by members of the ERV and LINE families. Following knockdown of wild-type (WT) TP53 expression, rescuing WT TP53 expression allows for partial recovery of the TE expression profile observed in the context of chronic TP53 expression. TP53 mutations R175H and R273H manifest their oncogenic characteristic partially through activating TE promoters in a cell type–specific manner. Lastly, we identified important sequence motifs that help govern the interactions between TEs and TP53, where TP53 activates TEs with TP53 binding motifs through direct binding and represses TEs indirectly via other pathways. Overall, we present a comprehensive profiling of the impact of TP53 on the activity of TE-derived promoters in isogenic cancer cell lines and provide a high-confidence TE expression atlas of TE promoters that are direct and indirect targets of TP53.

1 April 2019 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
JHJeffery Ho
Jeffery Ho
XLXianchun Li
Xianchun Li
LZLin Zhang
Lin Zhang
YLYonghao Liang
Yonghao Liang
WHWei Hu
Wei Hu
WWWilliam Wu
William Wu

4 July 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YLYonghao Liang
Yonghao Liang
TWTing Wang
Ting Wang